Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Did Structure Therapeutics (NASDAQ:GPCR) Stock Fall on September 29?

● Structure Therapeutics closed at $32.69 on Tuesday, September 29, down 6.77% from the prior close of $35.07.

Nitish Kishor | 30 September 2026

PacBio (NASDAQ:PACB) Jumps as a VA Genomics Contract Will Run on Its Revio Systems

● PacBio (PACB) closed at $1.71 on Monday, up about 5.6% from $1.62, trading between $1.59 and $1.80 during the session.

Nitish Kishor | 29 September 2026

Mirum Pharmaceuticals (NASDAQ:MIRM) Slips Despite a Positive Phase 3 Hepatitis Delta Readout

● Mirum Pharmaceuticals (MIRM) closed at $87.96 on Monday, down about 1.9% from $89.70, after trading between $84.71 and $91.25.

Nitish Kishor | 29 September 2026

Kodiak Sciences (NASDAQ:KOD) Rockets as Two Wet Macular Degeneration Drugs Win Phase 3 DAYBREAK Trials

● Kodiak Sciences (KOD) closed at $89.92 on Monday, up about 178% from $32.35, after positive Phase 3 DAYBREAK results.

Nitish Kishor | 29 September 2026

How Six-Month Dosing Hopes Turned Kodiak Sciences (NASDAQ:KOD) Into a Standout Biotech Winner

● Kodiak Sciences (KOD) closed at $89.92 on Monday, up about 178%, after Zenkuda data on longer dosing intervals.

Nitish Kishor | 29 September 2026

How Positive Phase 3 Data and a Planned Zenkuda Filing Powered Kodiak Sciences (NASDAQ:KOD)

● Kodiak Sciences (KOD) closed at $89.92 on Monday, about 178% above Friday's $32.35, after positive DAYBREAK data.

Nitish Kishor | 29 September 2026

How Contingent Value Rights Pushed Lifecore Biomedical (NASDAQ:LFCR) Above Its Cash Takeout Price

● Lifecore Biomedical (LFCR) closed at $6.52 on Monday, about 24 cents above the $6.28 cash price offered by Webster.

Nitish Kishor | 29 September 2026

Liquidia (NASDAQ:LQDA) Rallies as Strength Across Biotech Peers Lifts the Stock

● Liquidia (LQDA) closed at $73.67 on Monday, up about 7.7% from $68.43, while most of the market fell.

Nitish Kishor | 29 September 2026

MBX Biosciences (NASDAQ:MBX) Climbs on a Red Day for Wall Street

● MBX Biosciences (MBX) closed at $57.54 on Monday, up 7.3% from $53.63, while all three major indexes ended lower.

Nitish Kishor | 29 September 2026

Agenus (NASDAQ:AGEN) Jumps After Rodman & Renshaw Starts Coverage at Buy

● Agenus (AGEN) closed at $9.43 on Monday, up 10.4% from $8.54, after Rodman & Renshaw began coverage at Buy.

Nitish Kishor | 29 September 2026
Support

Hi! How can we help you today?

Loading…